The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood-brain barrier: a positron emission tomography study

Aim of this study was to determine whether the carbon-11-labelled antiepileptic drug [(11)C]mephobarbital is a substrate of P-glycoprotein (Pgp) and can be used to assess Pgp function at the blood-brain barrier (BBB) with positron emission tomography (PET). We performed paired PET scans in rats, wil...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mairinger, Severin, Bankstahl, Jens P., Kuntner, Claudia, Römermann, Kerstin, Bankstahl, Marion, Wanek, Thomas, Stanek, Johann, Löscher, Wolfgang, Müller, Markus, Erker, Thomas, Langer, Oliver
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3778256/
https://ncbi.nlm.nih.gov/pubmed/22342565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eplepsyres.2012.01.012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars